| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |